Page last updated: 2024-08-26

fulvestrant and sorafenib

fulvestrant has been researched along with sorafenib in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Brown, RE; Buryanek, J; Pfister, S; Rytting, ME; Vats, TS; Wolff, JE	1
Agard, DA; Duan, D; Elnatan, D; Logie, J; McLaughlin, CK; Shoichet, BK; Shoichet, MS; Torosyan, H	1
Du, X; Jacobson, MP; Lak, P; O'Donnell, H; Shoichet, BK	1

Reviews

1 review(s) available for fulvestrant and sorafenib

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for fulvestrant and sorafenib

Article	Year
Preliminary experience with personalized and targeted therapy for pediatric brain tumors. Pediatric blood & cancer, 2012, Jul-15, Volume: 59, Issue:1 Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Biomarkers, Tumor; Boronic Acids; Bortezomib; Brain Neoplasms; Child; Child, Preschool; Curcumin; Disease-Free Survival; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Infant; Male; Niacinamide; Phenylurea Compounds; Pyrazines; Pyridines; Sirolimus; Sorafenib; Survival Rate	2012

Article

Year

Preliminary experience with personalized and targeted therapy for pediatric brain tumors.

Pediatric blood & cancer, 2012, Jul-15, Volume: 59, Issue:1

Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Biomarkers, Tumor; Boronic Acids; Bortezomib; Brain Neoplasms; Child; Child, Preschool; Curcumin; Disease-Free Survival; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Infant; Male; Niacinamide; Phenylurea Compounds; Pyrazines; Pyridines; Sirolimus; Sorafenib; Survival Rate

2012

Other Studies

2 other study(ies) available for fulvestrant and sorafenib

Article	Year
Internal Structure and Preferential Protein Binding of Colloidal Aggregates. ACS chemical biology, 2017, 01-20, Volume: 12, Issue:1 Topics: Bacterial Proteins; beta-Lactamases; Colloids; Coloring Agents; Congo Red; DNA; Dynamic Light Scattering; Estradiol; Fluoresceins; Fulvestrant; Niacinamide; Peptides; Phenylurea Compounds; Protein Binding; Protein Folding; Proteins; Ribosomal Proteins; Scattering, Small Angle; Sorafenib; Trypsin; Trypsin Inhibitors; X-Ray Diffraction	2017
A Crowding Barrier to Protein Inhibition in Colloidal Aggregates. Journal of medicinal chemistry, 2021, 04-08, Volume: 64, Issue:7 Topics: Adsorption; Bacterial Proteins; beta-Lactamases; Colloids; Enzyme Assays; Fulvestrant; Kinetics; Malate Dehydrogenase; Protein Binding; Sorafenib	2021

Article

Year

Internal Structure and Preferential Protein Binding of Colloidal Aggregates.

ACS chemical biology, 2017, 01-20, Volume: 12, Issue:1

Topics: Bacterial Proteins; beta-Lactamases; Colloids; Coloring Agents; Congo Red; DNA; Dynamic Light Scattering; Estradiol; Fluoresceins; Fulvestrant; Niacinamide; Peptides; Phenylurea Compounds; Protein Binding; Protein Folding; Proteins; Ribosomal Proteins; Scattering, Small Angle; Sorafenib; Trypsin; Trypsin Inhibitors; X-Ray Diffraction

2017

A Crowding Barrier to Protein Inhibition in Colloidal Aggregates.

Journal of medicinal chemistry, 2021, 04-08, Volume: 64, Issue:7

Topics: Adsorption; Bacterial Proteins; beta-Lactamases; Colloids; Enzyme Assays; Fulvestrant; Kinetics; Malate Dehydrogenase; Protein Binding; Sorafenib

2021